We're accepting applications for our 2026-2027 Cardio-Oncology Fellowship, which includes a focus in advanced cardiac imaging training. Learn more and apply: medicine.yale.edu/internal-medic… Lauren A. Baldassarre, MD, FACC, FSCCT, FSCMR #cardiooncology #cardiotwitter

💡“Call early and call often.” In our latest #HFBeat episode, Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA joins hosts Michael H. Beasley, MD and Priya Umapathi to share 10 key takeaways from the 2025 ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock. From staging to shock teams

A YSM-led research team has developed a #bloodtest that could predict #heart #transplant rejection earlier and more easily, reducing the need for invasive biopsies: bit.ly/4lsBEw1

“What is missing is the bold step towards the international collaboration that has driven efficient evidence generation in other spheres,” says Marc Samsky and colleagues regarding improving evidence in cardiogenic shock. JACC Journals Yale Cardiology sciencedirect.com/science/articl…

In this JACC Journals podcast, Harlan Krumholz takes a "Deep Dive" into the SUMMIT CKD study, which reveals that tirzepatide improves symptoms, function, and weight in patients with HFpEF and obesity regardless of kidney function. Yale Cardiology jacc.org/digital-conten…

In this #AHFTC lecture series presentation, Dr. Ken Margulies provides a broad overview of the pathophysiological processes that drive the development of clinical heart failure. Yale Heart Failure Penn Cardiology youtu.be/ILU3Z8Y3tJo?si…

In this presentation, Stephanie Stocker explains how immunosuppressants work, their side effects, and possible drug interactions in heart transplant patients. #AHFTC Yale Heart Failure Yale New Haven Hosp YaleTransplant youtu.be/AURsjCdFfaE?si…

📋 What are the 10 things every clinician managing cardiogenic shock needs to remember? Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA breaks it down—from invasive hemodynamics to end-organ perfusion to team-based care. Listen to the latest #HFBeat podcast → 🔗 hfsa.org/heart-failure-… Michael H. Beasley, MD

“Know your level 1 center.” Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA emphasizes how critical it is for regional and community hospitals to form relationships with tertiary shock centers. Why? Because triage can determine survival. Explore this guidance on the latest #HFBeat episode. 🔗

🫀 From community ERs to cardiac ICUs—every institution has a role. The 2025 ACC Shock Guidance proposes a “team of teams” model across systems of care. Hear how shock networks—not just “hub and spoke”—are transforming outcomes. 🎧 Listen now → hfsa.org/heart-failure-…

When people talk about "telemonitoring" in heart failure, they can be talking about very different things. Great teamwork on this systematic review by Patrick Kwaah Barbara Malaga-Espinoza Kassem Farhat Ahmed Abdullah Emmanuel Olumuyide MD and collaboration with Michael H. Beasley, MD Lily K Stern MD

A true multidisciplinary shock team isn’t optional—it’s essential. 🫁 ER 🫀 Interventional 🧠 Critical care 🩺 Heart failure ⚕️ Surgery & ECMO The latest #HFBeat shows how the best teams coordinate care in minutes. 🔗 hfsa.org/heart-failure-… Michael H. Beasley, MD Priya Umapathi

New Episode of HF Beat: Gene Therapy in Genetic Cardiomyopathies 🧬 "Gene therapy isn’t science fiction anymore—it's here. 'We saw hearts shrink 40% in mass and troponins drop by 90%,' says Eric Adler on his groundbreaking Danon disease trial. Listen to how gene therapy is

“You can’t just round in the morning and hope for the best.” Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA urges clinicians to reassess cardiogenic shock patients every 2–4 hours—not every 8. It’s one of the biggest clinical practice shifts you’ll hear in this episode. 🎧 #HFBeat → hfsa.org/heart-failure-…

We know AI-ECG and AI-Echo can detect transthyretin amyloid cardiomyopathy (ATTR-CM), but: – How early can they pick up the phenotype? – Can we track its progression with digital biomarkers? Find out in our CarDS Lab study in EHJ Editor-in-Chief Thread below 🧵👇 w/ Rohan Khera

🧵 1/n We know #AI_ECG can detect HCM from ECG voltage signals. But raw signals aren't always accessible, limiting the use at the point-of-care. 🆕in Nature Cardiovascular Research, we ask: Can #AI detect #HCM directly from #ECG images? Across sites and ECG layouts? Rohan Khera CarDS Lab

For Heart Transplant Patients, Blood Test May Detect Rejection Earlier and More Easily m.yale.edu/c7sj

No biopsy required: Blood test could spot signs of rejection in heart transplant recipients cardiovascularbusiness.com/topics/clinica…

EHR nudges a bust for boosting guideline-directed meds in acute HF: PROMPT-AHF mdedge.com/fedprac/articl…

“A baby was on hospice. Six months later, she was treated with CRISPR. Today, she’s home.” – Dr. Eric Adler on what’s possible right now in gene therapy. #HFBeat → hfsa.org/heart-failure-… Eric Adler Michael H. Beasley, MD Priya Umapathi